When incubated with their substrates, human phosphomannomutase and L-3-phosphoserine phosphatase are known to form phosphoenzymes with chemical characteristics of an acyl-phosphate. The phosphorylated residue in phosphomannomutase has now been identified by mass spectrometry after reduction of the phosphoenzyme with tritiated borohydride and trypsin digestion. It is the first aspartate in a conserved DVDGT motif. Replacement of either aspartate of this motif by asparagine or glutamate resulted in complete inactivation of the enzyme. The same mutations performed in the DXDST motif of L-3-phosphoserine phosphatase also resulted in complete inactivation of the enzyme, except for the replacement of the second aspartate by glutamate, which reduced the activity by only about 40%. This suggests that the first aspartate of the motif is also the phosphorylated residue in L-3-phosphoserine phosphatase. Data banks contained seven other phosphomutases or phosphatases sharing a similar, totally conserved DXDX(T/V) motif at their amino terminus. One of these (␤-phosphoglucomutase) is shown to form a phosphoenzyme with the characteristics of an acyl-phosphate.
accomplished with a linear aqueous 5-100% acetonitrile gradient in 0.1% trifluoroacetic acid over 100 min at a flow rate of 80 l/min. Samples of the fractions were counted for radioactivity and analyzed by mass spectrometry.
All mass spectral analyses were performed on a Finnigan LCQ iontrap equipped with an electrospray source. The samples were introduced directly into the source at a flow rate of 2 l/min. The spray was obtained by applying a potential difference of 5 kV and with the help of a sheath gas (N 2 ) at 30 arbitrary units. The temperature of the heated capillary was 250°C. The LCQ was operated under manual control in the Tune Plus view with default parameters and active automatic gain control.
Site-directed Mutagenesis-Site-directed mutagenesis was performed by using Pwo polymerase and "back-to-back" mutated primers as described in Ref. 16 . The primers used to introduce the mutations corresponded to nucleotides 44 to 70 and 71 to 100 of the PMM1 sequence (EMBL U62526) and to nucleotides 224 to 259 and 260 to 295 of the human PSP cDNA (EMBL Y10275). The polymerase chain reaction was directly performed on a pET3d plasmid (17) containing the sequence of human PMM1 (12) . The plasmids were recircularized, amplified in Escherichia coli JM109, and checked by sequencing with the T7 primer using T7 Thermo Sequenase (Amersham), fluorescent primers, and the LI-COR automated DNA sequencer 4000L. For the PSP mutants, the polymerase chain reaction was performed using a pBlue-Script plasmid containing the coding sequence (11) . The amplified plasmids were recircularized and introduced into E. coli JM109. Clones were then sequenced with the M13F primer to confirm the presence of the mutations and rule out polymerase chain reaction errors. NdeI-BamHI fragments were then excised and ligated into pET3a.
Expression of the Recombinant Proteins-Bacteria BL21(DE3)pLysS (17) harboring the expression plasmids were grown aerobically in 0.5 liters of M9 medium at 37°C until A 600 reached 0.5-0.6. The culture was then maintained on ice for 60 min before addition of isopropylthiogalactoside to a final concentration of 0.4 mM. For PMM mutants, incubation was carried out at 18°C for 13 h, whereas PSP was expressed during 20 h at 37°C. Bacterial extracts were prepared and the recombinant enzymes purified by chromatography on DEAE-Sepharose as described in Ref. 11 . The wild-type PSP and the Asp 22 3 Glu mutant of this enzyme were further purified by chromatography on Sephacryl S-200 (11) .
Purification and Labeling of ␤-Phosphoglucomutase from Lactococcus lactis-L. lactis subsp. lactis AS211 (kindly provided by P. Radström, Lü nd, Sweden) was grown anaerobically for 14 h at 37°C in 3.5 liters of a medium containing 10 g/liter Bacto tryptone, 10 g/liter Bacto yeast extract, 2 g/liter casaminoacids, 5 g/liter KH 2 PO 4 , 5 g/liter K 2 HPO 4 , 1 g/liter MgSO 4 ⅐7H 2 O, and 20 g/liter maltose. The bacteria were collected by centrifugation at 5000 ϫ g and 4°C for 15 min, resuspended in a buffer containing 50 mM Hepes, pH 7.1, 2.5 g/ml leupeptin, 2.5 g/ml antipain, and 1 mM dithiothreitol and disrupted in a French press. The homogenate was centrifuged at 10,000 ϫ g and 4°C for 15 min, and the supernatant was applied onto a DEAE-Sepharose column (1.5 ϫ 15 cm) equilibrated in 50 mM Hepes, pH 7.1, 1 mM dithiothreitol. The column was washed with 60 ml of this buffer, and proteins were eluted with an NaCl gradient (0 -750 mM in 250 ml of the same buffer). The specific activity of the partially purified enzyme was Ϸ0.3 units/mg protein.
To study the formation of the phosphoenzyme, 0.02 units of the purified ␤-phosphoglucomutase was incubated at 0°C in a mixture (100 l) containing 50 mM Hepes, pH 7.1, 5 M glucose 1,6-bisphosphate, 1 M glucose 6-phosphate, 200,000 cpm of [ 32 P]glucose 6-phosphate, 1 mM dithiothreitol, 5 mM MgCl 2 , 1 mg/ml bovine serum albumin. The reaction was stopped after 10 min by the addition of 500 l of 5% ice-cold trichloroacetic acid, and the mixture was filtered on a polyethersulfone membrane (Supor 200, Gelman). The membrane was washed with 10 ml of ice-cold trichloroacetic acid and counted for radioactivity with 5 ml of HiSafe 2 scintillant.
To perform SDS-PAGE analysis, ␤-phosphoglucomutase was phosphorylated under the same conditions as described above, and the samples were processed as in Ref. 13 .
Computer Analysis-The BLAST program from the NCBI (18) was used to search for homologous proteins in data banks. Multiple sequence alignments were performed with the PILEUP algorithm (Wisconsin Package version 8, Genetics Computer Group, Madison, WI).
Enzyme and Protein Assays-PSP was assayed at 30°C by the release of L-[ 14 C]serine from L-3-[ 14 C]phosphoserine in an assay mixture (100 l) containing 25 mM Mes (pH 6.5), 1 mM MgCl 2 , 1 mM dithiothreitol, 0.1 mM L-3-phosphoserine for the human recombinant protein or 1 mM for the bacterial enzyme, 15,000 cpm of L-3-[ 14 C]phosphoserine, 0.1 mg/ml bovine serum albumin. Reactions were stopped by addition of 100 l of 10% HClO 4 . After centrifugation of the samples, the supernatants were neutralized with KHCO 3 and processed as described in Ref.
14.
PMM was assayed as described (13) except that the pH was 7.5 for the bacterial enzyme and 6.5 for the human recombinant protein. ␤-Phosphoglucomutase was assayed spectrometrically at 340 nm and 30°C through the reduction of NADP ϩ to NADPH. The assay mixture contained 50 mM Hepes, pH 7.1, 5 mM MgCl 2 , 0.25 mM NADP ϩ , 50 M glucose 1,6-bisphosphate, 500 M ␤-glucose 1-phosphate, and 10 g/ml yeast glucose 6-phosphate dehydrogenase.
One unit of enzyme is the amount catalyzing the formation of 1 mol of product per minute under the assay conditions described above. Protein was measured according to Bradford (19) with bovine gamma globulin as a standard.
RESULTS
Identification of the Phosphorylated Residue in Phosphomannomutase 1-Phosphoaspartyl and phosphoglutamyl residues are too labile to resist the procedure commonly used to identify phosphorylated residues, which involves digestion of the phosphorylated protein with trypsin, separation of the resulting peptides by HPLC, and sequencing of the phosphorylated peptide. We therefore used the method of Degani and Boyer (20) , in which the carboxyl-phosphate group is reduced with tritiated borohydride to a hydroxymethyl group before further processing of the protein. Radioactivity screening allows the detection of fractions containing the modified peptide. Furthermore, the replacement of a carboxyl group by a hydroxymethyl group results in a 14-dalton decrease of the molecular mass that allows the localization of the modified residue by mass spectrometry (21) .
Human PMM1, incubated with (phosphorylated) or without (control) mannose 1,6-bisphosphate, was reduced by [ 3 H]NaBH 4 and submitted to digestion with trypsin. The peptides were separated by HPLC. As shown in Fig. 1 , two peaks of radioactivity were found both with the control (C) and the phosphorylated (P) enzymes. The first one was significantly broader in the case of the column loaded with the phosphorylated reduced enzyme, due to the presence of much more radio- From the sequence of PMM1 (12), only two peptides (DVDGTLTPAR and LLSKQTIQN) have calculated monoisotopic masses in agreement with the measured mass of 1044.2 amu, and only the first one is compatible with the cleavage specificity of trypsin and chymotrypsin, a common contaminant of trypsin preparations. It is indeed preceded by a phenylalanine and ends with an arginine. Fragmentation of this 1044 m/z peptide by tandem mass spectrometry (not shown) confirmed its identity, the most abundant ions obtained (m/z 929, 830, and 715) corresponding to fragments y 9 , y 8 , and y 7 (by convention, amino-and carboxyl-terminal fragments resulting from cleavage of the peptide bond are symbolized by b and y, respectively (22)).
Fragmentation of the 1030 m/z peptide yielded y fragments of the same size as cleavage of the 1044 m/z peptide, indicating that the two peptides differed from each other by the replacement of the amino-terminal aspartate by homoserine ( Fig. 2 ) and, therefore, that the phosphorylated residue in PMM1 is Asp 19 . This residue is the first in a completely conserved DVDGT motif present in eukaryotic PMMs (Ref. 12; see also below). The fact that no ions with m/z 915 or 816 were found among fragments of the reduced peptide indicates that the second aspartate was not phosphorylated.
Fraction 22 of both columns contained two peptides (with m/z 1609.6 and 1595.7) that differed by 14 amu (not shown). The mass of the peptide with m/z 1609.6 indicated that it corresponded to a tryptic peptide of PMM1 with sequence TVGHSVVSPQDTVQR. Its most abundant fragment ions (m/z 1409, 1215, 1029, 930, and 503, corresponding to y 13 , y 11 , y 9 , y 8 , and y 4 ) confirmed this interpretation. Fragmentation of the 1595.7 m/z peptide yielded a series of y ions with the same m/z as listed above, indicating that the structural difference between the two peptides resided at the level of the first three residues (not shown). This difference could possibly result from reduction of a peptide bond to a secondary amine.
The second peak of radioactivity of both columns was also analyzed. In both cases, it contained 1483.5 and 1469.5 m/z ions, which yielded fragments of m/z 1318, 1205, 929, and 814 and 1304, 1191, 915, and 800, respectively. Thus, the m/z 1483.5 peptide was the one with sequence GNETSPGGND-FEIF, the fragments corresponding to b 13 , b 12 , b 10 , and b 9 . This peptide is preceded by a phenylalanine in the sequence of PMM1 and results therefore from chymotryptic digestion. The 1469.5 m/z peptide is reduced in its first nine amino acids.
Site-directed Mutagenesis of Phosphomannomutase 1-To confirm the conclusion of the mass spectrometry analysis, we constructed PMM1 mutants in which we replaced separately the two aspartates of the conserved motif DVDGT by either glutamate or asparagine. Preliminary experiments indicated that the mutant proteins were insoluble when expressed at 37°C. Expression was therefore carried out at 18°C, not only for the mutated proteins but also for the human wild-type enzyme. Extracts prepared 13 h after addition of isopropylthiogalactoside to the culture contained activities (0.003-0.006 units/mg protein) that were much lower in the case of the mutated proteins than in that of the human wild-type enzyme (1.8 units/mg protein) and in fact comparable with the activity observed in a control culture without translatable insert (0.006 unit/mg protein).
All of these extracts were chromatographed on DEAE-Sepharose. When extracts containing the human wild-type enzyme were applied on the column, the elution profile of the PMM activity (Fig. 3A) coincided with that of the overexpressed 30-kDa polypeptide (not shown), as determined by SDS-PAGE analysis. When bacterial extracts containing the mutant proteins were chromatographed, the peak of PMM activity was about 500-fold lower, as in columns performed with control E. coli extracts. Furthermore, it did not correspond with the peak of recombinant protein, the amount of which was comparable with that of wild-type PMM. These results are exemplified for mutant Asp 19 3 Glu in Fig. 3, A and B . Thus, the enzymic activity measured in these cases corresponded to the E. coli enzyme. This was confirmed by the finding that this small enzymic activity had always a pH optimum (7.5), a K m for mannose 1-phosphate (50 M), and a K a for mannose 1,6bisphosphate (1 M) similar to those of the bacterial enzyme and distinctly different from those of human wild-type PMM (pH 6.5, 3 and 5 M, respectively).
Studies on L-3-Phosphoserine Phosphatase-We attempted to determine the phosphorylation site of PSP by using the same approach as described above for PMM1. The enzyme was phosphorylated by incubation with a saturating concentration (20 mM) of its substrate, in the presence of 20 mM L-serine, to slow down the hydrolysis of the phosphoenzyme, precipitated with trichloroacetic acid, reduced with tritiated borohydride, and digested with trypsin. However, no distinct narrow peak of radioactivity could be found in the eluate of the column, presumably because of the low stoichiometry of phosphate incorporation into the enzyme (11) .
We have previously noticed (11) that PSPs contain close to their amino terminus a conserved DXDST motif. As this motif is similar to the DVDGT sequence found in PMM, it was likely to contain the phosphorylation site of PSP. To investigate this possibility, we mutated the two aspartate residues of the DX-DST motif to asparagine and glutamate, as described above for New Class of Phosphotransferases PMM1. Expression was carried out at 37°C for 18 h. PSP activity was measured in cell extracts. For three of the four mutants (Asp 20 3 Glu, Asp 20 3 Asn, Asp 22 3 Asn), an activity of only about Ϸ0.015 unit/mg protein was found, comparable with the activity present in control E. coli extracts (0.014 unit/ mg) and well below the activity found with a culture harboring a plasmid encoding the wild-type enzyme (0.53 unit/mg protein). For the fourth mutant, in which the second aspartate is replaced by a glutamate, the activity (0.33 unit/mg protein) was about 60% that of the wild-type extract.
All of these extracts were chromatographed on DEAE-Sepharose columns. Fractions were analyzed by SDS-PAGE, and PSP activity was assayed (not shown). For the wild-type enzyme and mutant Asp 22 3 Glu, there was a perfect coincidence between the elution profile of the activity and that of the overexpressed 28-kDa protein. In contrast, for mutants Asp 20 3 Glu, Asp 20 3 Asn, and Asp 22 3 Asn, the elution profile of the recombinant polypeptide was similar to that of the wildtype human enzyme and did not correspond with that of the low residual activity, indicating that the latter was contributed by the bacterial enzyme. Furthermore, the enzyme assayed in these three cases had a K m for L-3-phosphoserine of 100 M and, when assayed by the release of L-[ 14 C]serine from L-3-[ 14 C]phosphoserine, was not inhibited by L-serine; these two properties correspond to those of the bacterial enzyme. These results indicate that the Asp 20 3 Glu, Asp 20 3 Asn, and Asp 22 3 Asn mutants are devoid of activity. The Asp 22 3 Glu mutant and the wild-type enzymes were further purified by gel filtration on Sephacryl S-200. At this stage, they were nearly homogeneous, as judged by SDS-PAGE, and their specific activity was Ϸ3 units/mg protein for the Asp 22 3 Glu mutant and Ϸ6.5 units/mg protein for the wild-type enzyme.
Sequence Comparisons-The results mentioned above showed that a region containing a DXDXT motif was important for the function of PSP and of PMM. To find other enzymes with the same or a related motif, we performed a BLAST search (18) in the GenBank and EMBL data banks using the sequence of both enzymes, and we performed additional searches with the sequences of the homologous enzymes that were found. For all enzymes identified in this way, we aligned sequences from different species to check the conservation of the motifs. As shown in Fig. 4 , several enzymes were indeed found to possess 19 3 Glu mutant enzyme. Bacterial extracts containing about 300 mg of protein in 25 ml were loaded onto a DEAE-Sepharose column (20 ϫ 1.6 cm), which was washed with 50 ml of a buffer containing 10 mM Hepes, pH 7.1, 2.5 g/ml antipain and leupeptin, and 1 mM dithiothreitol. Retained protein was eluted with an NaCl gradient (0 -500 mM). Fractions of 2 ml were collected. A, PMM activity was measured. B, 30 l of the fractions were analyzed by SDS-PAGE and Coomassie Blue staining.
FIG. 3. Elution profiles of PMM from DEAE-Sepharose columns loaded with control bacterial extracts or extracts containing wild-type (WT) PMM1 or the Asp

FIG. 4. Comparison of the phosphorylated sequence in PMM with conserved motifs found in other phosphotransferases and in L-2-haloacid dehalogenase.
For each enzyme, the completely conserved residues are shown in bold. The alignment shows only five of the numerous ATPases whose sequences are known. For all other enzymes, all identified sequences are shown. Underlined enzymes have been shown to form a covalent intermediate when incubated with their substrate; the modified residue, if identified, is indicated with an asterisk. In the case of paranitrophenylphosphatase from Schizosaccharomyces pombe, an intronic sequence corresponding to nucleotides 1062-1108 was removed from the gene sequence (EMBL X62722) to obtain the amino acid sequence shown in the figure. a motif related to that found in PMM and PSP. Several of these enzymes were previously identified (23) as belonging to a large family of hydrolases comprising phosphatases (PSP, trehalose 6-phosphate phosphatase, phosphoglycolate phosphatase, histidinol phosphatase, and paranitrophenylphosphatase) as well as 2-L-haloacid dehalogenase and epoxide hydrolase. We added to this list two mutases (PMM and ␤-phosphoglucomutase), glycerol 3-phosphate phosphatase, and P-ATPases, and we removed epoxide hydrolase because the amino-terminal motif (DLDGV) found in the human and rodent enzymes (24, 25) is actually not conserved in this protein family (see "Discussion"). In all sequences shown in Fig. 4 , the first aspartate is strictly conserved and is preceded most often by four hydrophobic residues. The second aspartate is found in all phosphotransferases and phosphatases acting on phosphomonoesters shown in Fig. 4 but is replaced by a threonine in ATPases and by a tyrosine in dehalogenases. The threonine found in position ϩ4 with respect to the phosphorylated aspartate is conserved in all enzymes except ␤-phosphoglucomutases and paranitrophenylphosphatases.
Formation of a Phosphoenzyme with ␤-Phosphoglucomutase-The results mentioned above imply that all phosphotransferases shown in Fig. 4 should form, when incubated with their substrate, an aspartyl-phosphoenzyme. Evidence for this formation has been provided for ATPases, as well as for several of the phosphotransferases possessing the DXDXT motif, i.e. PMM, PSP, and 2-phosphoglycolate phosphatase (26) . It was of interest to confirm this for ␤-phosphoglucomutase, in which the conserved threonine is replaced by a valine. ␤-Phosphoglucomutase was partially purified from L. lactis by chromatography on DEAE-Sepharose and was completely separated from ␣-phosphoglucomutase. Incubation of the enzyme with [ 32 P]glucose 6-phosphate in the presence of glucose 1,6bisphosphate resulted in the incorporation of radioactivity into protein. SDS-PAGE analysis indicated that the labeled peptide had a M r of 25,000, in good agreement with the molecular mass calculated from the sequence (24,210 Da). The phosphoenzyme bond was completely hydrolyzed after 10 min of incubation in 1 M NaOH at 0°C or in 0.2 M NH 2 OH (pH 5.3) at 20°C and about 40% hydrolyzed after 15 min of incubation at 37°C in M HCl (results not shown), in agreement with an acyl-phosphate bond (27) .
DISCUSSION
Identification of the Residue Phosphorylated in Phosphomannomutase 1-The residue phosphorylated in PMM1 was hypothesized (13) to be an aspartate or a glutamate on the basis of the stability of the phosphoenzyme linkage (27) . Its location in the sequence could be identified after reduction of phosphoaspartate to homoserine with radiolabeled borohydride, proteolytic digestion, and separation of the peptides by HPLC. The elution profile of the tryptic/chymotryptic peptides derived from the phosphorylated enzyme showed indeed an additional reduced peptide that could be unambiguously identified based on its molecular mass, the size of its fragments, and the known sequence of PMM1. The fragmentation results showed additionally that the phosphorylated residue was the first aspartate in the a DVDGT motif.
Two other reduced peptides could be detected in the digests of both control and phosphorylated enzymes. Both peptides could be identified by mass spectrometry, and the position of the reduced bond could be assigned to one of the first three residues of the peptide with m/z 1595.7 and to one of the first nine residues of the peptide with m/z 1469.5. In the case of the first peptide, this excludes reduction of a carboxyl-phosphate group, as the implicated sequence does not contain an aspartate or a glutamate residue. We speculate that the 14-amu loss is due to reduction of a peptide bond to a secondary amine due to a local effect of the amino acid sequence. The fact that both peptides were found with the control and the phosphorylated enzymes indicates that the underlying modifications are probably not related to the catalytic mechanism.
Site-directed mutagenesis confirmed the importance of the two aspartate residues in the DVDGT motif of PMM; their rather conservative replacement by a glutamate or by an asparagine resulted in a complete loss of activity. The fact that the mutated proteins had conserved the same behavior upon chromatography indicated that the loss of activity was not due to a gross folding problem (28) .
Identification of the Phosphorylated Residue in L-3-Phosphoserine Phosphatase-We could not detect the modified residue in PSP with the same methodology as applied for PMM, probably because the phosphorylation stoichiometry of this enzyme is about 10 times lower than that of the mutase (11, 13) . The mutagenesis studies showed, however, that the first of the two aspartate in the conserved DXDST motif could not be replaced by glutamate or by asparagine without total loss of activity, whereas the second aspartate could be replaced by glutamate, although not by asparagine, with conservation of substantial activity. This result indicates that the carboxylic group of the first aspartate is much more position sensitive for its function than that of the second aspartate, which fits very well with the notion that it would participate in catalysis as a nucleophile, the second aspartate playing possibly a role as an acid-base catalyst (see below). These considerations, as well as the analogy with PMM, indicate that the first of the two aspartates is the phosphorylated residue.
A Family of Phosphotransferase with a DXDX(T/V) Motif-Sequence comparisons indicate that at least nine phosphatases or phosphomutases contain a similar, totally conserved DX-DX(T/V) motif, which is located in the amino-terminal region of the protein, or in the case of the bifunctional enzyme, trehalose 6-phosphate synthase/trehalose 6-phosphate phosphatase, in the amino-terminal region of the trehalose 6-phosphatase domain. This motif is particularly striking in the case of some enzymes like phosphoglycolate phosphatase, trehalose 6-phosphatase, PSP, and paranitrophenylphosphatase, in which only 8 -14% of the residues are strictly conserved (not shown). For four of these enzymes (phosphoglycolate phosphatase (26), PSP (11), PMM (13), ␤-phosphoglucomutase (this paper)), evidence for a phosphoenzyme intermediate with the characteristics of a carboxyl-phosphate bond has been provided. For one of them (PMM), the phosphorylated residue could be definitely identified as the first of the two aspartates; for a second one (PSP), site-directed mutagenesis is highly suggestive of this (see above). We speculate that the same aspartate is phosphorylated in the other members of this protein family. With at least nine members, this new family of phosphotransferases seems to be slightly larger than the bisphosphoglycerate mutase family, which comprises two mutases and three phosphatases and in which the phosphorylated residue is a histidine in a conserved RHG motif (29, 30) .
Several of the members of the new phosphotransferase family were previously identified by Koonin and Tatusov (23) as belonging to a large hydrolase family comprising several phosphatases, L-2-haloacid dehalogenases, and epoxide hydrolase. This family is characterized by the presence of a conserved aspartate in the amino-terminal region and by two less well conserved motifs further in the sequence. This aspartate, which aligns with the first one of the DXDX(T/V) motif, was shown in the case of L-2-haloacid dehalogenase to participate in catalysis by attacking the second carbon of L-2-haloacids to form a dehalogenated ester (31). Koonin and Tatusov correctly pointed out that, by analogy with the dehalogenases, the as-partate of the phosphatases must covalently bind the phosphate group of their substrate. Their protein family does, however, not comprise the two phosphomutases studied here but includes mammalian epoxide hydrolase. This enzyme contains a DLDGV sequence (24, 25) that is, however, not conserved in other homologous epoxide hydrolases such as the enzymes from soybean (EMBL D63780) and Mycobacterium tuberculosis (EMBL Z95557). Furthermore, murine epoxide hydrolase was shown to form a covalent adduct with its substrate at the level of Asp 333 (32) in a sequence that is unrelated to our motif. Therefore, we speculate that the conserved DXDX(T/V) motif is a characteristic of the phosphatases/phosphomutases acting on phosphate esters (as opposed to phosphoanhydrides).
Sequence comparisons indicate that a third group of enzymes, i.e. P-ATPases, contains an extremely conserved, related motif (DKTGT), in which again the first aspartate is phosphorylated in the course of catalysis (8) . Interestingly, the residue in third position is an aspartate in the phosphoesterase/phosphomutase family, a threonine in the ATPase family, and a tyrosine in the dehalogenase family. On the basis of its position in the crystal structure of 2-L-haloacid dehalogenase and of site-directed mutagenesis studies, this tyrosine was proposed to play a role in attracting the leaving halide ion during attack of C2 of L-2-haloacids by the aspartate (33) . We speculate that the second aspartate of the phosphomonoesterases/mutases plays the role of an acid that donates the proton to the leaving hydroxyl group. This role is not needed in the case of ATPases because the leaving group is a dissociated acid. Accordingly, the second aspartate is replaced by a much weaker acid in ATPases.
Aravind and Koonin (34) recently identified a new phosphoesterase family with a DXD motif, comprising Drosophila prune protein and bacterial RecJ exonuclease as well as numerous proteins with unidentified function. This family differs from the one described here by at least two characteristics: (a) the presence of another conserved DHH motif, which is found in none of the sequence reported here, and (b) the fact that the DXD motif is not preceded by a stretch of four hydrophobic residues. It would be most interesting to know if these enzymes also form a phosphoaspartate intermediate.
